Avanos Medical, Inc. AVNS 深 滬
已收盤 09-19 16:00:00 美东时间
11.91
-0.370
-3.01%
華盛通- 最 高12.27
- 今 開12.27
- 成交量 131.35万股
- 最 低 11.85
- 昨 收 12.28
- 總市值 5.53亿
- 52周最高 24.23
- 市盈率 靜 --
- 換手率 2.83%
- 52周最低 9.303
- 委 比 61.54%
- 總股本 4640.25万
- 歷史最高 72.96
- 量 比 2.28
- 振 幅 3.42%
- 歷史最低 9.303
- 每 手 1
- 風險率 1.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Avanos Medical Acquires Nexus Medical for Growth
Avanos Medical ( ($AVNS) ) has shared an update. On September 15, 2025, Avanos ...
09-15 19:29
Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs
Kimberly-Clark will pay $40.4 million to settle a criminal charge after selling mislabeled surgical gowns.
08-30 00:53
Avanos maintains $665M–$685M revenue target amid HA divestiture and tariff impact
Earnings Call Insights: Avanos Medical, Inc. (AVNS) Q2 2025 Management View David C. Pacitti, CEO, announced key leadership changes, stating, "it's my great pleasure to announce that Scott Galovan, pr...
08-06 01:27
Avanos Medical Appoints SVP Scott Galovan As SVP, CFO Effective Aug. 1, 2025
Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025. Galovan
08-05 18:48
Avanos Medical Affirms FY2025 Adj EPS Guidance of $0.75-$0.95 vs $0.85 Est; Affirms FY2025 Sales Guidance of $665.000M-$685.000M vs $672.000M Est
2025 OUTLOOK Estimated RangeDiluted earnings per share (GAAP)$
08-05 18:34
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CM...
08-01 04:15
美敦力重磅人事变动
来源 | 医疗器械创新网 2025年7月1日，全球医疗器械龙头美敦力（Medtronic）宣布一项重磅人事任命：现任碧迪医疗（BD）高级副总裁、总法律顾问米歇...
07-02 19:39
Avanos Medical Navigates Growth Amid Tariff Challenges
Avanos Medical, Inc. (($AVNS)) has held its Q1 earnings call. Read on for the m...
05-07 08:14
Avanos Medical Lowers FY2025 GAAP EPS Guidance from $0.63-$0.86 to $0.33-$0.56
Avanos Medical (NYSE:AVNS) lowers FY2025 GAAP EPS guidance from $0.63-$0.86 to $0.33-$0.56..
05-06 19:03
